JPRN-UMIN000003207CompletedPhase 1
Phase I study of peptide vaccination for patients with biliary tract cancer - Phase I study of peptide vaccination for patients with biliary tract cancer
Tokyo Women's Medical University0 sites9 target enrollmentStarted: February 19, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 9
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Pregnancy or lactation 2.Decision of unsuitableness by principal investigator 3.Patient with severe underlying disease 4.Patient with severe allergy disease
Investigators
Similar Trials
Completed
Phase 1
Phase I study of peptide vaccination for patients with unresectable biliary tract cancerbiliary tract cancerJPRN-UMIN000003229Tokyo Women's Medical University9
Completed
Phase 1
Phase I study of peptide vaccination for patients with unresectable pancreatic cancerPancreatic cancerJPRN-UMIN000004337Tokyo Women's Medical University9
Completed
Phase 1
Phase II study of peptide vaccination for patients with metastatic lung or gastro-intestinal tract cancerslung cancer, pharyngeal cancer, gastric cancer, jejunal cancer, ileal cancer, pancreas cancer, biliary tract cancer, soft tissue sarcomaJPRN-UMIN000002857Tohoku University Hospital14
Completed
Phase 1
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiopancreatic cancerJPRN-UMIN000002022Department of Gastroenterology, Juntendo University School of Medicine36
Completed
Phase 1
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent gastric cancer to be refractory to chemotherapy by using new tumor antigen URLC10 and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiogastric cancerJPRN-UMIN000002409Department of Gastroenterology, Juntendo University School of Medicine36